Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Living in a virus-controlled world

As the coronavirus pandemic continues to infect populations, though in some countries it is slowing, talk has shifted to re-opening economies, and to manufacturing a vaccine that drug companies hope will not only work, but can be distributed at large enough doses to provide ...

US between Scylla and Charybdis

I’m just going to come right out and say it: The United States is not equipped to deal with a pandemic. The nation of 327 million, despite having the number one economy in the world, and by far the most powerful military, is shockingly ill-prepared, not only ...

The S&P 500 Bulls Are Readying Their Response

Stocks have invalidated their breakout above the 50% Fibonacci retracement. Apart from this key development, what else can we deduce from yesterday’s price moves around stocks? And in light of today’s premarket upswing, would these indications s...

Could the coronavirus cause the next ‘Arab Spring’?

The rich are getting richer, inequality is on the rise, and the middle class, the backbone of the US economy since the 1950s, is shrinking. In 2018 the three highest-paid chief executives in the United States earned more than the output of several countries. Tesla&Close...

Another Day, Another S&P 500 Reversal

Bucking Tuesday’s breakdown below the 50% Fibonacci retracement, stocks have pushed higher yesterday to return back around this key resistance level. The bears have suffered a setback yesterday, but it proved important to wait for the session close in order to ...

Economic stimulus can’t save US from deflation and recession

One of the worst weeks on Wall Street mercifully ended on Friday. S&P 500 DJIA Nasdaq After multiple sessions of panic selling, the markets caught an up-draft after US President Trump declared a national emergency over the coronavirus, thus freeing u...

Bayer, EXMceuticals, Symrise - investing in the healthcare growth market

The Corona Pandemic brings with it many changes. The influences in the supply chain are affecting the economy to the point of stagnation. The lack of contact for people creates challenges in coping with everyday life. The term 'home office' is used in an inflationary way - and...

BioNTech, Gilead, Memphasys - in the spotlight of investors overnight

There are topics and products that are the focus of general interest overnight. Often these are needs or problems that require a time-critical solution. The current situation surrounding the spread of the Corona Virus COVID-19 has brought numerous companies into the focus of i...

Coronavirus Strikes Back. But Force Is Strong With Gold

We all fear the second wave of infections. But the U.S. hasn’t even controlled the first one! Bad news for Americans, but good news for gold. Please take a look at the chart below. As you can see, the epidemiological situation in the United States d...

BioNTech, Eastman Kodak, EXMceuticals - investors have the chance to profit

The importance of health has not been as clear for a long time as it was in 2020. Detached from the discussion about the specifics of COVID-19 on mortality compared to other viruses, the need for protection is great and helplessness without a medical response is harmful to the...
1 2 3 4 5 6 7 8 9 10 ...